NB BIOGLIM MF 1/500 SR is a combination medication designed to aid individuals managing Type 2 Diabetes, especially when blood glucose levels remain uncontrolled with monotherapy. This formulation employs a dual-action mechanism to effectively lower glucose levels through two key ingredients: Gliclazide and Metformin. Gliclazide, a sulfonylurea, stimulates the pancreas to release insulin after meals, thereby reducing spikes in blood sugar levels. It also supports the maintenance of pancreatic beta-cell function and possesses some antioxidant properties. On the other hand, Metformin, a biguanide, primarily reduces glucose production in the liver and enhances the sensitivity of muscle and adipose tissues to insulin, allowing for more effective use of available insulin. Additionally, Metformin decreases the absorption of glucose from the intestines. This dual mechanism not only allows for more substantial glucose control but also addresses various pathways involved in metabolic management, resulting in a notable reduction in HbA1c levels, a critical marker of long-term blood sugar control. The medication also offers cardiovascular benefits and can assist with weight maintenance or loss, which is particularly beneficial for many patients with Type 2 Diabetes. By consistently managing blood sugar levels, NB BIOGLIM MF 1/500 SR plays a vital role in preventing long-term complications associated with diabetes and promotes overall health. The convenience of a single tablet combining both therapeutic agents simplifies treatment adherence, making it easier for patients to follow their prescribed regimen.